Concepedia

Publication | Open Access

Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties

DOIFull Paper Access

241

Citations

45

References

2011

Year

Jeffrey L. Nordstrom, Sergey Gorlatov, Wenjun Zhang, Yinhua Yang, Ling Huang, Steve Burke, Hua Li, Valentina Ciccarone, Téngfēi Zhāng, Jeffrey B. Stavenhagen,
Breast Cancer Research

Abstract

The data support the clinical development of MGAH22, which may have utility in patients with low HER2 expressing tumors or carrying the CD16A low-binding allele.

References

YearCitations

Page 1